MATCH-R: A Preclinical Platform of Resistant Models to Innovative Therapies • Highlighting the development of a panel

Time: 2:15 pm
day: Day Two

Details:

  • Highlighting the development of a panel of PDX models and organoids derived from biopsies collected at the stage of acquired resistance
  • Demonstrating how these preclinical models will be used to improve knowledge on the mechanisms underlying resistance to treatment
  • Exploring the impact on evaluating response to new treatment

Speakers: